C-Rad ABLTS:0R44 82 Forward Dividend Yield % is 0.28% as of Jun. 29, 2026. GuruFocus rates LTS:0R44 with a GF Score™ of 82/100 and a GF Value™ of kr31.78 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 315 Medical Devices & Instruments companies, C-Rad AB ranks worse than 95.56% on this metric.
As of today (2026-06-29), the Forward Annual Dividend Yield of C-Rad AB is 0.28%.
As of today (2026-06-29), the Trailing Annual Dividend Yield of C-Rad AB is 0.28%.
LTS:0R44's Forward Dividend Yield % is ranked worse than 95.56% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs LTS:0R44: 0.28
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
C-Rad AB (LTS:0R44) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
LTS:0R44 vs ABT, SYK, MDT: Forward Dividend Yield % Comparison
For the Medical Devices subindustry, C-Rad AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
C-Rad AB Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where C-Rad AB's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
C-Rad AB Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
SEK 0.100000
2026-05-08
2026-05-11
2026-05-15
Cash Dividend
annually
SEK:SEK 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
C-Rad AB's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.1
/
35.90
=
0.28 %
Current Share Price is kr35.90. C-Rad AB's Dividends per Share for the forward twelve months is calculated as kr0.1 * 1 = kr0.1.
C-Rad AB's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.1
/
35.90
=
0.28 %
Current Share Price is kr35.90. C-Rad AB's Dividends per Share for the trailing twelve months (TTM) ended in Today is kr0.1.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 0.28% mean?
C-Rad AB (LTS:0R44) has a Forward Dividend Yield % of 0.28% as of Jun. 29, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on C-Rad AB and its competitors. According to the industry distribution chart, C-Rad AB ranks #301 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 95.6%.
Is C-Rad AB's Forward Dividend Yield % too high?
C-Rad AB's current Forward Dividend Yield % is 0.28%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.06. C-Rad AB's value of 0.28% is 86.4% below this industry median. Based on the distribution chart, C-Rad AB ranks #301 out of 315 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, C-Rad AB has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does C-Rad AB's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, C-Rad AB ranks #301 out of 315 companies for Forward Dividend Yield %. This places C-Rad AB in the lower half of its industry. The industry median Forward Dividend Yield % is 2.06. C-Rad AB's value of 0.28% is 86.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.06, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. C-Rad AB's current Forward Dividend Yield % of 0.28% is 86.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on C-Rad AB and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. C-Rad AB's current Forward Dividend Yield % is 0.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-Rad AB stock overvalued right now?
Based on GuruFocus' analysis, C-Rad AB (LTS:0R44) is currently considered Modestly Overvalued. The stock's GF Value™ is kr31.78, compared to a current price of kr35.90 — trading 13% above its estimated fair value. The current Forward Dividend Yield % is 0.28% and 86.4% below the Medical Devices & Instruments industry median of 2.06. C-Rad AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For C-Rad AB (LTS:0R44), the current Forward Dividend Yield % is 0.28% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is C-Rad AB (LTS:0R44) Overvalued in 2026?
Based on GuruFocus' analysis, C-Rad AB stock appears to be overvalued.
The current stock price of kr35.90 is trading 13% above its estimated GF Value™ of kr31.78.
GuruFocus considers C-Rad AB to be Modestly Overvalued.
Key valuation signals for LTS:0R44:
Forward Dividend Yield %: 0.28%
GF Value™: kr31.78 vs. price of kr35.90 (13% above fair value)
Industry Position: 86.4% below the Medical Devices & Instruments median (#301 of 315)
No single metric tells the full story. See the LTS:0R44 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.
82GF Score
Get the complete analysis for LTS:0R44
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0R44 has been successfully added to your 